Carbamic acid, N-[(1S)-1-(3,6-dibromo-2-pyridinyl)-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester

医药中间体 · — · —

医药中间体Confidentiality：公开

INN / Generic Name: Carbamic acid, N-[(1S)-1-(3,6-dibromo-2-pyridinyl)-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester
Dosage Form: —
Strength: —
Therapy Area: Pharmaceutical Intermediates
Indication: API: Lenacapavir sodium
Current Status: 官方中间体目录（API: Lenacapavir sodium）
GMP Certification: —
CEP: No
DMF Type: —
Stability Data: —
BE Required: Not required / waivable
Registration Pathway: FSO 供货（非注册物质）
MOQ: 询价
Lead Time: 询价
Price Range: 询价

Registrable Markets

Global

Process / Sequence / Exact Price